Substance Use Disorder — Preventing Persistent Post-Surgical Pain and Opioid Use In At-Risk Veterans: Effect of ACT
Citation(s)
Abyholm AS, Hjortdahl P [The pain takes hold of life. A qualitative study of how patients with chronic back pain experience and cope with their life situation]. Tidsskr Nor Laegeforen. 1999 Apr 30;119(11):1624-9. Norwegian.
Dindo L, Recober A, Marchman JN, Turvey C, O'Hara MW One-day behavioral treatment for patients with comorbid depression and migraine: a pilot study. Behav Res Ther. 2012 Sep;50(9):537-43. doi: 10.1016/j.brat.2012.05.007. Epub 2012 May 27.
Ip HY, Abrishami A, Peng PW, Wong J, Chung F Predictors of postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology. 2009 Sep;111(3):657-77. doi: 10.1097/ALN.0b013e3181aae87a. Review.
Kerns RD, Otis J, Rosenberg R, Reid MC Veterans' reports of pain and associations with ratings of health, health-risk behaviors, affective distress, and use of the healthcare system. J Rehabil Res Dev. 2003 Sep-Oct;40(5):371-9.
Kerns RD, Sellinger J, Goodin BR Psychological treatment of chronic pain. Annu Rev Clin Psychol. 2011;7:411-34. doi: 10.1146/annurev-clinpsy-090310-120430. Review.
McCracken LM, Velleman SC Psychological flexibility in adults with chronic pain: a study of acceptance, mindfulness, and values-based action in primary care. Pain. 2010 Jan;148(1):141-7. doi: 10.1016/j.pain.2009.10.034. Epub 2009 Nov 28.
McCracken LM, Vowles KE A prospective analysis of acceptance of pain and values-based action in patients with chronic pain. Health Psychol. 2008 Mar;27(2):215-20. doi: 10.1037/0278-6133.27.2.215.
Otis JD, Keane TM, Kerns RD, Monson C, Scioli E The development of an integrated treatment for veterans with comorbid chronic pain and posttraumatic stress disorder. Pain Med. 2009 Oct;10(7):1300-11. doi: 10.1111/j.1526-4637.2009.00715.x.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.